VB

Vijay B. Samant

Chief Executive Officer, Director

Xiconic Pharmaceuticals

Therapeutic Areas

Xiconic Pharmaceuticals Pipeline

DrugIndicationPhase
XCN-010Multiple cancers (e.g., breast, lung, prostate, ovarian, lymphoma)Pre-clinical